Physician profile
Patrick W Linson
NPI 1184618175
$1,320.79
in general payments reported to CMS, 2019-2025
18 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $19.06 · 2022: $112 · 2023: $137 · 2024: $235 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $249.12 | 2022-2023 | Rezum Generator |
| Brainlab, INC. | $234.16 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $146.28 | 2024-2025 | Opdivo |
| Janssen Biotech, INC. | $137.86 | 2019-2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $119.34 | 2024 | |
| Merck Sharp & Dohme LLC | $91.70 | 2019-2025 | Keytruda, Welireg |
| Sumitomo Pharma America, INC. | $47.94 | 2025 | Orgovyx |
| Astellas Pharma US INC | $44.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $38.97 | 2024-2025 | |
| Seagen INC. | $38.63 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.24 | 2019 | |
| Fennec Pharmaceuticals, INC. | $25.42 | 2025 | Fyarro |
| Celgene Corporation | $23.61 | 2019 | |
| Pfizer INC. | $22.16 | 2025 | |
| Emd Serono, INC. | $20.23 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Puma Biotechnology, INC. | $17.83 | 2019 | |
| Blue Earth Diagnostics | $17.13 | 2024 | |
| Eisai INC. | $16.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Linson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.